Navigation Links
AtheroNova Signs Agreement for Development of Clinical Trial Supplies
Date:4/25/2012

IRVINE, Calif., April 25, 2012 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to regress atherosclerotic plaque, today announced that it has signed an agreement with Frontage Laboratories, Inc. to commence work on the formulation, compounding and tabletization of the Company's AHRO-001 product in advance of the upcoming Phase I human clinical studies. Frontage, based in Exton, Pennsylvania, is one of the leading pharmaceutical contract research organizations (CROs) in the United States.  They will immediately commence work on the analysis, formulation and validation of the various processes and procedures for manufacturing AHRO-001 tablets.

"Frontage has been extremely diligent in dealing with the technical and physical requirements of our AHRO-001 compound and we look forward to commencing our project in the coming days," said AtheroNova CEO Thomas W. Gardner.  "We are very confident that Frontage will deliver a quality product in a timely manner. We continue to adhere to our vigorous development path and anticipate additional exciting development milestones in the coming months."

"We are pleased to be working with the fine people from Frontage on this project as we continue to engage with quality industry partners," commented Dr. Balbir Brar, Senior Vice President of Drug Development. "Our utmost confidence stems from previous projects I have worked on with Frontage and have always found their people, facilities and product quality to be some of the best in the industry."

Frontage CEO, Dr. Song Li, also commented on the agreement, stating "It is an honor to work with AtheroNova on this vital clinical trial materials project.  Frontage's 10-year history of delivering pharmaceutical R&D services in a fast and efficient manner means the millions of patients suffering from atherosclerosis are that much closer to a potential cure."

About AHRO
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Agrees With AtheroNovas Clinical Development Plan as Proposed
2. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
3. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
4. Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
5. Fortis Healthcare Signs Agreement Giving Indias Fastest-Growing Hospital Chain Access to Masimos State-of-the-Art Noninvasive Patient Monitoring Solutions
6. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
7. Altitude Organic New Dispensary Counter-Space Acquisition Program - Zazzz™ - Signs Premier Location
8. Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets
9. QRxPharma Signs License and Option Agreement with Actavis
10. Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
11. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... MALVERN, Pa. , March 31, 2015  SCILEX ... commercialization of products focused on the treatment of pain, ... Tokyo Japan ), a member of ITOCHU ... one of the three leading sogo shosha (general trading ... a strategic investment in SCILEX.  ICF has worked closely ...
(Date:3/31/2015)... 31, 2015  SynCardia Systems, Inc. has received FDA ... study on the effective use of its 50cc SynCardia ... The FDA approval will allow SynCardia ... heart failure patients. Patients enrolled in this study will ... bridge to a donor heart transplant. (Caution-In the ...
(Date:3/31/2015)... /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), ... marijuana products and a licensed producer ("LP") to cultivate ... Canada ) ("MMPR"), is pleased to announce ... the District of Saanich confirming ... now allows for commercial distribution of medical marijuana under ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
(Date:3/31/2015)... Chicago, Illinois (PRWEB) March 31, 2015 ... NetZoom Visio Stencils Device Library for documenting and ... the following Visio Stencils: , Manufacturer / ... Dell PowerEdge r720, Dell PowerEdge r520, Dell PowerEdge ... IBM Power 8 Series, EMC VMAX 100K, VMAX ...
(Date:3/31/2015)... South Bend, Indiana (PRWEB) March 31, 2015 ... by Lee DeRose in Youngstown, Ohio in 1987. ... ahead of the curve with not just customer ... that has been added to the well-stocked arsenal ... (HRMS) manufactured by American Green Technology® (AGT). The ...
(Date:3/31/2015)... Burns Engineering announces 3-Day Quick Ship on ... & Beverage, Pharmaceutical and Biotech markets. These field proven sensors ... are now available as part of Burns’ Quick Ship Program ... S01 and S03 with 1/8” and 1/4” diameters respectively ... in process lines 1/4” and larger. Sensors are available ...
(Date:3/31/2015)... AB (PRWEB) March 31, 2015 ... to patients of Calgary and surrounding areas. External ... patients with coronary artery disease, specifically stable coronary ... EECP or ECP, is used extensively all over ... disease and now Calgarians (Albertans) are extremely fortunate ...
(Date:3/31/2015)... India Network Foundation , sponsor of Visitor ... to all USA bound international travelers on health insurance ... higher than many other countries and procedures cost many ... a coronary artery bypass graft costs about $22,694 in ... Visitors are advised to get a thorough medical ...
Breaking Medicine News(10 mins):Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:American Green Technology® Signs Exclusive Agreement to Distribute Health Risk Management System in Midwest 2Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:New Heart Disease Treatment Called External Counterpulsation (EECP) helps people of Alberta Who Have Failed or Are Not Suitable For Heart Stents or Surgery 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3
... has created particles that closely mirror some of the key ... for the development of synthetic blood. The new discovery ... Edition of the Proceedings of the National Academy of ... also could lead to more effective treatments for life threatening ...
... , MONDAY, Jan. 10 (HealthDay News) -- The H1N1 swine ... create a vaccine that can protect people against multiple strains ... who were infected with the H1N1 virus and recovered had ... wide variety of flu strains. The virus matched typical ...
... Alan Mozes HealthDay Reporter , MONDAY, Jan. 10 ... who smokes face an increased risk for developing high blood ... Warning that children with high blood pressure often become adults ... poses a substantial and long-term risk to the cardiovascular welfare ...
... Nationwide Children,s Hospital report a gene therapy strategy that ... inherited blood disorder, Beta Thalassemia. The gene correction ... a batch of embryonic stem cell lines. Some of ... gene and can thus be used for transplantation-based treatments ...
... A paper describing a dramatic change during the 20th century ... and mortality from liver cirrhosis features in Alcohol and ... among higher social classes in the early part of the ... much more common among the lower social classes by the ...
... , , Reproductive medicine is one of ... there are announcements of medical ,firsts, new rulings by ... heated debate among practitioners in the field, ethicists, legislators, ... is the forum where more than 9,000 of the ...
Cached Medicine News:Health News:UNC researchers inch closer to unlocking potential of synthetic blood 2Health News:UNC researchers inch closer to unlocking potential of synthetic blood 3Health News:People Who Recovered From H1N1 Offer Clues to Better Vaccine 2Health News:Secondhand Smoke Tied to High Blood Pressure in Kids 2Health News:Secondhand Smoke Tied to High Blood Pressure in Kids 3Health News:Embryonic stem cells help deliver 'good genes' in a model of inherited blood disorder 2Health News:Embryonic stem cells help deliver 'good genes' in a model of inherited blood disorder 3Health News:Social class and changes in mortality from liver cirrhosis over the 20th Century 2Health News:ESHRE bridges East and West for its 2012 Congress in Istanbul 2
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... Threaded Anchors (3.0mm) are ideal for soft tissue ... surgical applications. The FASTIN threaded anchor technology offers ... surgical sites. If you need a threaded anchor ... the FASTIN anchor is the anchor for you. ...
Medicine Products: